Preoperative magnetic resonance imaging in breast cancer: Meta-analysis of surgical outcomes

Annals of Surgery

Volumn 257, Issue 2, 2013, Pages 249-255

  Houssami, Nehmat ^a   Turner, Robin ^a   Morrow, Monica ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

breast cancer; breast conserving surgery; magnetic resonance imaging; mastectomy; meta analysis; re excision surgery

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; HISTOLOGY; HUMAN; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; SURGICAL RISK; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; NEOPLASM STAGING; PREOPERATIVE PERIOD; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84872308255     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31827a8d17     Document Type: Article

References (29)

1. Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;378:1804-1811.
2. Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43:1905-1917.
3. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: Cancer J Clin. 2007;57:75-89.
4. Houssami N, Morrow M. Pre-operative breast MRI in women with recently diagnosed breast cancer-where to next? Breast. 2010;19:1-2.
5. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248-3258.
6. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA: Cancer J Clin. 2009;59:290-302.
7. Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386-391.
8. Kuhl C, Kuhn W, Braun M, et al. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast. 2007;16(suppl 2):S34-S44.
9. Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol. 2008;26:352-353.
10. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46:1296-1316.
11. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27:5640-5649.
12. Ciatto S. Pre-operative breast MRI: what do women want? Breast. 2010;19:435-436.
13. American College of Radiology (ACR). ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. 2008. Available at: http://www.acr.org. Accessed January 2012.
14. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563-571.
15. Peters NH, van ES, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET- randomised controlled trial. Eur J Cancer. 2011;47:879-886.
16. Pengel KE, Loo CE, Teertstra HJ, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat. 2009;116:161-169.
17. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreat-ment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;294;209:180-187.
18. Hwang N, Schiller DE, Crystal P, et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol. 2009;16:3000-3009.
19. Miller B, Abbott A, Tuttle T. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol. 2012;19:536-540.
20. Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2010;119:415-422.
21. McGhan LJ, Wasif N, Gray RJ, et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol. 2010;17(suppl 3):255-262.
22. Heil J, Buhler A, Golatta M, et al. Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol. 2011;18: 2143-2149.
23. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27: 2466-2473.
24. Mamounas EP, Tang G, Fisher B, et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol. 2010;28:1677-1683.
25. Millar EK, Graham PH, O'Toole SA, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol. 2009;27:4701-4708.
26. Kyndi M, Sorensen FB, Knudsen H, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419-1426.
27. Turnbull LW, Brown SR, Olivier C, et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess (Winchester, England). 2010;14:1-182.
28. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735-2742.
29. Nichols HB, Berrington de GA, Lacey JV, Jr, et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29:1564-1569.